Fasting plasma peptide YY concentrations are increased in patients with major depression who associate weight loss

Journal of Endocrinological Investigation

Volumn 35, Issue 7, 2012, Pages 645-648

  Gimenez Palop O ^a   Coronas, R ^a   Cobo, J ^a   Gallart, L ^b   Barbero, J D ^a   Parra, I ^a   Fuste G ^a   Vendrell, J ^b   Bueno, M ^a   Gonzalez Clemente J M ^a   Caixas A ^a  

^a PARC TAULÍ HOSPITAL UNIVERSITARI   (Spain)

^b HOSPITAL UNIVERSITARI JOAN XXIII   (Spain)

Author keywords

BDNF; Depression; Ghrelin; Peptide yy; Weight

Indexed keywords

ANTIDEPRESSANT AGENT; BRAIN DERIVED NEUROTROPHIC FACTOR; GHRELIN; PEPTIDE YY;

ADULT; ANTHROPOMETRIC PARAMETERS; ARTICLE; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DIET RESTRICTION; DISEASE ASSOCIATION; FEMALE; HORMONE BLOOD LEVEL; HUMAN; MAJOR DEPRESSION; MALE; PROTEIN BLOOD LEVEL; WEIGHT REDUCTION;

ACETYLATION; ADULT; APPETITE REGULATION; BODY MASS INDEX; BRAIN-DERIVED NEUROTROPHIC FACTOR; CASE-CONTROL STUDIES; COHORT STUDIES; DEPRESSIVE DISORDER, MAJOR; EATING DISORDERS; FEMALE; GHRELIN; HUMANS; MALE; MIDDLE AGED; PEPTIDE YY; SELF REPORT; WEIGHT LOSS;

EID: 84865765209     PISSN: 03914097     EISSN: 17208386     Source Type: Journal    
DOI: 10.3275/8180     Document Type: Article

References (25)

1. Castañeda TR, Tong J, Datta R, Culler M, Tschöp MH. Ghrelin in the regulation of body weight and metabolism. Front Neuroendocrinol 2010, 31: 44-60.
2. Kirchner H, Tong J, Tschöp MH, Pfluger PT. Ghrelin and PYY in the regulation of energy balance and metabolism: lessons from mouse mutants. Am J Physiol Endocrinol Metab 2010, 298: E909-19.
3. Giménez-Palop O, Giménez-Pérez G, Mauricio D, et al. A lesser postprandial suppression of plasma ghrelin in Prader-Willi syndrome is associated with low fasting and a blunted postprandial PYY response. Clin Endocrinol (Oxf) 2007, 66: 198-204.
4. Cowansage KK, LeDoux JE, Monfils MH. Brain-derived neurotrophic factor: a dynamic gatekeeper of neural plasticity. Curr Mol Pharmacol 2010, 3: 12-29.
5. Bariohay B, Roux J, Tardivel C, Trouslard J, Jean A, Lebrun B. Brain-derived neurotrophic factor/tropomyosin-related kinase receptor type B signalling is a downstream effector of the brainstem melanocortin system in food intake control. Endocrinology 2009, 150: 2646-53.
6. Bocchio-Chiavetto L, Bagnardi V, Zanardini R, et al. Serum and plasma BDNF levels in major depression: a replication study and meta-analyses. World J Biol Psychiatry 2010, 11: 763-73.
7. Sugahara H, Akamine M, Kondo T, et al. Somatic symptoms most often associated with depression in an urban hospital medical setting in Japan. Psychiatry Res 2004, 128: 305-11.
8. nd ed. New York: Springer-Verlag 1996, 53.
9. Leucht S, Engel RR. The relative sensitivity of the Clinical Global Impressions Scale and the Brief Psychiatric Rating Scale in antipsychotic drug trials. Neuropsychopharmacology 2006, 31: 406-12.
10. Kojima S, Nakahara T, Nagai N, et al. Altered ghrelin and peptide YY responses to meal in bulimia nervosa. Clin Endocrinol (Oxf) 2005, 62: 74-8.
11. Stock S, Leichner P, Wong A, et al. Ghrelin, peptide YY, glucose-dependent insulinotropic polypeptide, and hunger responses to a mixed meal in anorexic, obese, and control female adolescents. J Clin Endocrinol Metab 2005, 90: 2161-8.
12. Misra M, Miller KK, Tsai P, et al. Elevated peptide YY levels in adolescent girls with anorexia nervosa. J Clin Endocrinol Metab 2006, 91: 1027-33.
13. Nakahara T, Kojima S, Tanaka M, et al. Incomplete restoration of the secretion of ghrelin and PYY compared to insulin after food ingestion following weight gain in anorexia nervosa. J Psychiatr Res 2007, 41: 814-20.
14. Utz AL, Lawson EA, Misra M, et al. Peptide YY (PYY) levels and bone mineral density (BMD) in women with anorexia nervosa. Bone 2008, 43: 135-9.
15. Olszanecka-Glinianowicz M, Kocelak P, Wikarek T, et al. Are plasma ghrelin and PYY concentrations associated with obesity-related depression? Endokrynol Pol 2010, 61: 174-7.
16. Widerlöv E, Lindström LH, Wahlestedt C, Ekman R. Neuropeptide Y and peptide YY as possible cerebrospinal fluid markers for major depression and schizophrenia, respectively. J Psychiatr Res 1988, 22: 69-79.
17. Essah PA, Levy JR, Sistrun SN, Kelly SM, Nestler JE. Effect of weight loss by a low-fat diet and a low-carbohidrate diet on peptide YY levels. Int J Obes (Lond) 2010, 34: 1239-42.
18. Beckman LM, Beckman TR, Earthman CP. Changes in gastrointestinal hormones and leptin after Rou-en-Y gastric by-pass procedure: a review. J Am Diet Assoc 2010; 110: 571-84.
19. Veith RC, Lewis N, Linares OA, et al. Sympathetic nervous system activity inmajor depression. Basal and desipramine-induced alterations in plasma norepinephrine kinetics. Arch Gen Psychiatry 1994; 51: 411-22.
20. Zhang T, Uchida T, Gomez G, Lluis F, Thompson JC, Greeley GH Jr. Neural regulation of peptide YY secretion. Regul Pept 1993, 48: 321-8.
21. Schanze A, Reulbach U, Scheuchenzuber M, Groschl M, Kornhuber J, Kraus T. Ghrelin and eating disturbances in psychiatric disorders. Neuropsychobiology 2008, 57: 126-30
22. Kluge M, Schussler P, Schmid D, et al. Ghrelin plasma levels are not altered in major depression. Neuropsychobiology 2009; 59: 199-204.
23. Barim AO, Aydin S, Colak R, Dag E, Deniz O, Sahin I. Ghrelin, paraoxonase and arylesterase levels in depressive patients before and after citalopram treatment. Clin Biochem 2009; 42: 1076-81.
24. Diniz BS, Teixeira AL, Talib LL, Mendonça VA, Gattaz WF, Forlenza OV. Serum brain-derived neurotrophic factor level is reduced in antidepressant-free patients with late-life depression. World J Biol Psychiatry 2010; 11: 550-5.
25. Ziegenhorn AA, Schulte-Herbrüggen O, Danker-Hopfe H, et al. Serum neurotrophins-a study on the time course and influencing factors in a large old sample. Neurobiol Aging 2007; 28: 1436-45.